Page last updated: 2024-08-26

sivelestat and Esophageal Neoplasms

sivelestat has been researched along with Esophageal Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, H; Baba, Y; Hirashima, K; Iwatsuki, M; Karashima, R; Kinoshita, K; Kurashige, J; Nagai, Y; Watanabe, M1
Fujimura, T; Funaki, H; Fushida, S; Inaba, H; Kawahara, Y; Kayahara, M; Nakagawara, H; Ninomiya, I; Oyama, K; Tajima, H; Takamura, H1
Iwahashi, M; Naka, T; Nakamori, M; Nakamura, M; Ojima, T; Yamaue, H1
Akiyama, H; Endo, I; Kosaka, T; Kunisaki, C; Makino, H; Morita, S1
Ando, S; Hirasawa, M; Makuuchi, H; Matsuda, M; Nishiyama, J; Suzuki, T1
Hinohara, H; Kadoi, Y; Kunimoto, F; Kuwano, H; Ogata, K; Yamaki, E1
Hamai, Y; Hihara, J; Mizuiri, H; Oeda, M; Sanada, Y; Shigematsu, H; Suzuki, T; Tanabe, K; Tsutani, Y; Ukon, K; Wada, Y; Yoshida, K1
Akamoto, S; Izuishi, K; Okano, K; Sano, T; Suzuki, Y; Usuki, H; Wakabayashi, H; Yachida, S1
Funakoshi, Y; Hashimoto, S; Ishizaka, A; Kitagawa, Y; Kitajima, M; Maruyama, I; Miyasho, T; Okamoto, M; Ozawa, S; Saikawa, Y; Suda, K; Tasaka, S; Ueda, M; Yamada, S; Yokota, H1

Trials

5 trial(s) available for sivelestat and Esophageal Neoplasms

ArticleYear
Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2010, Volume: 23, Issue:4

    Topics: Acute Lung Injury; Aged; Double-Blind Method; Esophageal Neoplasms; Esophagectomy; Female; Glycine; Humans; Male; Middle Aged; Perioperative Care; Postoperative Complications; Prospective Studies; Proteinase Inhibitory Proteins, Secretory; Serine Proteinase Inhibitors; Sulfonamides; Thoracic Surgery, Video-Assisted

2010
Optimal period for the prophylactic administration of neutrophil elastase inhibitor for patients with esophageal cancer undergoing esophagectomy.
    World journal of surgery, 2011, Volume: 35, Issue:7

    Topics: Aged; Esophageal Neoplasms; Esophagectomy; Female; Glycine; Humans; Lung Diseases; Male; Middle Aged; Postoperative Care; Postoperative Complications; Prospective Studies; Proteinase Inhibitory Proteins, Secretory; Serine Proteinase Inhibitors; Sulfonamides; Time Factors

2011
Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer.
    The British journal of surgery, 2011, Volume: 98, Issue:7

    Topics: Aged; Critical Care; Esophageal Neoplasms; Esophagectomy; Female; Glycine; Humans; Intraoperative Care; Length of Stay; Lymph Node Excision; Male; Middle Aged; Postoperative Complications; Proteinase Inhibitory Proteins, Secretory; Sulfonamides; Thoracic Surgery, Video-Assisted

2011
[Effects of neutrophil elastase inhibitor on postoperative cytokine levels in patients after esophagectomy].
    Masui. The Japanese journal of anesthesiology, 2005, Volume: 54, Issue:8

    Topics: Cytokines; Esophageal Neoplasms; Esophagectomy; Glycine; Humans; Interleukin-8; Leukocyte Elastase; Lung Diseases; Postoperative Complications; Postoperative Period; Respiration, Artificial; Serpins; Sulfonamides; Time Factors

2005
Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery.
    Surgery today, 2007, Volume: 37, Issue:5

    Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Digestive System Neoplasms; Digestive System Surgical Procedures; Esophageal Neoplasms; Esophagectomy; Female; Glycine; Humans; Interleukin-6; Leukocyte Elastase; Liver Neoplasms; Male; Middle Aged; Pancreaticoduodenectomy; Postoperative Period; Prospective Studies; Serine Proteinase Inhibitors; Single-Blind Method; Stress, Physiological; Sulfonamides; Th1 Cells; Th2 Cells

2007

Other Studies

4 other study(ies) available for sivelestat and Esophageal Neoplasms

ArticleYear
Preventive effect of sivelestat on postoperative respiratory disorders after thoracic esophagectomy.
    Surgery today, 2013, Volume: 43, Issue:4

    Topics: Acute Lung Injury; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Drug Administration Schedule; Drug Therapy, Combination; Esophageal Neoplasms; Esophagectomy; Female; Glycine; Humans; Intraoperative Care; Male; Methylprednisolone; Middle Aged; Postoperative Care; Postoperative Complications; Respiratory Distress Syndrome; Respiratory Function Tests; Retrospective Studies; Serine Proteinase Inhibitors; Sulfonamides; Systemic Inflammatory Response Syndrome; Treatment Outcome

2013
The effects of the early administration of sivelestat sodium, a selective neutrophil elastase inhibitor, on the postoperative course after radical surgery for esophageal cancer.
    Surgery today, 2012, Volume: 42, Issue:7

    Topics: Acute Lung Injury; Aged; C-Reactive Protein; Esophageal Neoplasms; Esophagectomy; Female; Glycine; Humans; Inflammation; Length of Stay; Male; Middle Aged; Oxygen; Perioperative Period; Postoperative Complications; Proteinase Inhibitory Proteins, Secretory; Retrospective Studies; Sulfonamides; Survival Rate

2012
Neutrophil elastase induces cell proliferation and migration by the release of TGF-alpha, PDGF and VEGF in esophageal cell lines.
    Oncology reports, 2007, Volume: 17, Issue:1

    Topics: Cell Growth Processes; Cell Line, Tumor; Cell Movement; ErbB Receptors; Esophageal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Glycine; Humans; Leukocyte Elastase; MAP Kinase Signaling System; Platelet-Derived Growth Factor; Sulfonamides; Transforming Growth Factor alpha; Vascular Endothelial Growth Factor A

2007
Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2007, Volume: 20, Issue:6

    Topics: Aged; Combined Modality Therapy; Enzyme Inhibitors; Esophageal Neoplasms; Esophagectomy; Female; Glycine; Humans; Leukocyte Elastase; Male; Middle Aged; Postoperative Period; Sulfonamides; Treatment Outcome

2007